New Key Statistics Module, Z-Score and F-Score
NAS:IONS Key Ratios
| Market Cap $ M | 6,114.46 |
| Enterprise Value $ M | 5,423.81 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 21.42 |
| Price/Sales | 6.94 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 813.00 |
| EPS (TTM) $ | -2.52 |
| Beneish M-Score | -2.5 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -20.24 |
| EV-to-EBITDA | -22.09 |
| PEG | -- |
| Shares Outstanding M | 157.71 |
| Net Margin (%) | -44.96 |
| Operating Margin % | -44.87 |
| Pre-tax Margin (%) | -43.33 |
| Quick Ratio | 7.51 |
| Current Ratio | 7.61 |
| ROA % (ttm) | -12.74 |
| ROE % (ttm) | -108.17 |
| ROIC % (ttm) | -67.50 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.33 |
IONS Number of Guru Trades
IONS Volume of Guru Trades
Gurus Latest Trades with NAS:IONS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:IONS is held by these investors
Total 4
Ionis Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:IONS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers